At biotech's smallest companies, female executives make up only a fraction of C-suite leaders — report
Despite repeated calls to diversify the biotech industry, women and those in minority groups make up just 14% of board members at public micro- and small-cap companies, according to a new report by the Bedford Group and Transearch.
“Just the total percentage of CEOs [who] are female was much lower than anticipated,” said Darren Raycroft, partner and managing director at the Bedford Group.
For over a decade, the firm has compiled executive compensation reports in other verticals. But for the first time, they’re releasing a report based on 225 public biotech companies in the US with market caps under $2 billion — and what they found was a stark lack of diversity among the highest ranks of the industry.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 129,300+ biopharma pros reading Endpoints daily — and it's free.